A new Yale SOM study finds that training generative AI to understand why headlines resonate—not just which perform best—reduces clickbait and produces more engaging, trustworthy content, pointing to a ...

A new Yale SOM study finds that training generative AI to understand why headlines resonate—not just which perform ...

We asked Yale SOM’s Zoe Chance, an expert on consumer behavior and persuasion, what makes boycotts effective and how companies should respond.

Yale SOM’s Jeffrey Sonnenfeld and co-author Stephen Henriques write that a new comprehensive housing law gives Connecticut ...

How do political differences affect workplace performance? A study of professional golfers, co-authored by Yale SOM’s Balázs Kovács, suggests that working alongside someone of the opposite political ...

How do political differences affect workplace performance? A study of professional golfers, co-authored by Yale SOM’s Balázs Kovács, suggests that working alongside someone of the opposite political ...

Howie and Harlan are joined by Harvard internist Jerry Avorn to discuss his research on the pharmaceutical industry and his work promoting evidence-based prescribing. Harlan highlights new results ...

Before 2022, Tesla was known as a leader in building electric cars and a favorite of the eco-conscious. Then CEO Elon Musk bought and transformed Twitter, campaigned with Donald Trump, and spent ...

Howie and Harlan are joined by Yale School of Medicine immunologist Akiko Iwasaki, a leading authority on vaccines and long COVID. Harlan reflects on America's crisis of trust in federal agencies; ...

Yale SOM leadership expert Jeffrey Sonnenfeld and co-author Stephen Henriques write that the tangle of AI deals among tech giants could be signs of dangerous overinvestment in the developing ...

In the view of Yale SOM health economist Jason Abaluck, drugs like the blockbuster semaglutide—better known under the brand names Ozempic and Wegovy—are pretty close to miracle treatments. “Of all the ...